NewsSource: EClinCloud

EClinCloud Product Overview | eLearning Training System

2 min readEClinCloud Editorial Team
News header image for EClinCloud Product Overview | eLearning Training System

Source: EClinCloud. Author: EClinCloud.


The EClinCloud eLearning training system is an internet-based distance learning system used primarily for system operation and update training across EClinCloud subsystems, internal corporate training, and rater training. Through the EClinCloud eLearning system, training tasks and courses can be customized and published with real-time reminders, while learners can access training content and complete assessments anytime and anywhere to meet diverse training and assessment needs.


computer-ai.png

AI-driven all-in-one product + service solution


šŸ” What does EClinCloud offer?

ā—‰ eLearning system

ā—‰ System training



šŸ’» EClinCloud eLearning system features




ā—‰ Targeted assignment of learning tasks by department, role, or individual, with unified assessment management

ā—‰ Flexible configuration based on organizational needs to support different types of projects and courses

ā—‰ Online assessments provide immediate evaluation of training outcomes and automatically generate certificates for tracking and analysis

ā—‰ Coordinates with rater training to strengthen scale comprehension and clarify rating criteria



šŸ’” Why choose EClinCloud eLearning?


ā– Clear, concise learning interface with an easy-to-use task and course publishing workflow

ā– Connected with EClinCloud subsystems to effectively monitor user proficiency across subsystems

ā– Comprehensive reports on tasks, courses, and training status to help management evaluate training effectiveness

ā– Supports rater training, standardizes training workflows, and provides documentation for compliance review






About EClinCloud


EClinCloud is a leading AI company in the clinical research industry, building an AI-driven integrated clinical intelligence cloud platform and endpoint assessment technologies to provide pharmaceutical companies and research institutions worldwide with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services. These build efficient, precise digital solutions and leverage AI predictive models and an intelligent data platform to dynamically assess and help improve drug clinical trial success rates, helping shorten drug and device development cycles for the benefit of patients.  







Article illustration





Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled ā€œPractice and Application of AI in Clinical Research,ā€ sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.